RYAN SPECIALTY REPORTS FIRST QUARTER 2026 RESULTS

1 RYAN SPECIALTY REPORTS FIRST QUARTER 2026 RESULTS - Total Revenue grew 15.2% year-over-year to $795.2 million - - Organic Revenue Growth Rate* of 11.8% year-over-year - - Net Income of $40.6 million, or $0.13 per diluted share - - Adjusted EBITDAC* grew 15.7% year-over-year to $232.0 million - - Adjusted Net Income increased 21.2% year-over-year to $130.7 million - - Adjusted Diluted Earnings Per Share grew 20.5% or $0.47 per diluted share - - Returned approximately $64.8 million to shareholders, including $40.0 million of share repurchases, and $24.8 million of dividends and distributions - April 30, 2026 | CHICAGO, IL — Ryan Specialty Holdings, Inc. (NYSE: RYAN) (“Ryan Specialty” or the “Company”), a leading international specialty insurance firm, today announced results for the first quarter ended March 31, 2026. First Quarter 2026 Highlights •Revenue grew 15.2% year-over-year to $795.2 million, compared to $690.2 million in the prior-year period •Organic Revenue Growth Rate* was 11.8% for the quarter, compared to 12.9% in the prior-year period •Net Income increased year-over-year to $40.6 million, compared to a loss of $(4.4) million in the prior-year period. Diluted Earnings Per Share was $0.13 •Adjusted EBITDAC* increased 15.7% to $232.0 million, compared to $200.5 million in the prior-year period •Adjusted EBITDAC Margin* of 29.2%, compared to 29.1% in the prior-year period •Adjusted Net Income* increased 21.2% to $130.7 million, compared to $107.8 million in the prior-year period •Adjusted Diluted Earnings Per Share* increased 20.5% to $0.47, compared to $0.39 in the prior-year period •Returned approximately $64.8 million to shareholders through $40.0 million of Class A common stock repurchases, representing 1.0 million shares, and $24.8 million of dividends and distributions “It was a strong start to 2026 for Ryan Specialty in the face of continued and increasing industry headwinds,” said Patrick G. Ryan, Founder and Executive Chairman of Ryan Specialty. “We grew total revenue 15%, driven by organic growth of 11.8% and contributions from M&A. We grew Adjusted EBITDAC by 15.7% and Adjusted Diluted EPS by 20.5%. Our performance this quarter speaks to the dedication of our team, their ability to succeed in challenging times, and the diversified enterprise we have purposefully built over the years. Through one of the most efficient and effective insurance distribution platforms in the word, we are delivering innovative solutions for our clients - brokers, agents, and carriers, that are difficult to replicate elsewhere. While we expect the environment to remain considerably challenging in the near term, we are confident that our continued investment in the platform, paired with our ability to innovate alongside our clients and capital trading partners, will further strengthen our position as a leader in specialty insurance.” “I am proud of our team's tireless execution during the quarter as we continue to win business and increase market share in a very competitive environment,” added Timothy W. Turner, Chief Executive Officer of Ryan Specialty. “Along with our strong performance, we are continuing to invest broadly in our technology, AI, and data capabilities to ensure we are providing our clients with the expertise and advocacy they expect to solve their most complex 2 insurance needs. We remain focused on controlling what we can control given the challenging environment. We are enhancing our competitive advantage and continuing to build and expand a platform that is designed to endure across market cycles.” Summary of First Quarter 2026 Results Three Months Ended March 31, Change (in thousands, except percentages and per share data) 2026 2025 $ % GAAP financial measures Total revenue $795,229 $690,166 $105,063 15.2% Net commissions and fees 782,903 676,128 106,775 15.8 Compensation and benefits 495,176 430,289 64,887 15.1 General and administrative 108,761 106,060 2,701 2.5 Total operating expenses 700,633 589,931 110,702 18.8 Operating income 94,596 100,235 (5,639) (5.6) Net income (loss) 40,597 (4,389) 44,986 NM Net income (loss) attributable to Ryan Specialty Holdings, Inc. 17,646 (27,642) 45,288 NM Compensation and benefits expense ratio (1) 62.3 % 62.3 % General and administrative expense ratio (2) 13.7 % 15.4 % Net income (loss) margin (3) 5.1 % (0.6 %) Earnings (loss) per share (4) $0.14 $(0.22) Diluted earnings (loss) per share (4) $0.13 $(0.22) Non-GAAP financial measures* Organic revenue growth rate 11.8 % 12.9 % Adjusted compensation and benefits expense $461,832 $397,428 $64,404 16.2 % Adjusted compensation and benefits expense ratio 58.1 % 57.6 % Adjusted general and administrative expense $101,365 $92,237 $9,128 9.9 % Adjusted general and administrative expense ratio 12.7 % 13.4 % Adjusted EBITDAC $232,033 $200,501 $31,532 15.7 % Adjusted EBITDAC margin 29.2 % 29.1 % Adjusted net income $130,728 $107,839 $22,889 21.2 % Adjusted net income margin 16.4 % 15.6 % Adjusted diluted earnings per share $0.47 $0.39 $0.08 20.5 % *For a definition and a reconciliation of Organic revenue growth rate, Adjusted compensation and benefits expense, Adjusted compensation and benefits ratio, Adjusted general and administrative expense, Adjusted general and administrative expense ratio, Adjusted EBITDAC, Adjusted EBITDAC margin, Adjusted net income, Adjusted net income margin, and Adjusted diluted earnings per share to the most directly comparable GAAP measure, see “Non-GAAP Financial Measures and Key Performance Indicators” below. (1)Compensation and benefits expense ratio is defined as Compensation and benefits divided by Total revenue. (2)General and administrative expense ratio is defined as General and administrative expense divided by Total revenue. (3)Net income margin is defined as Net income divided by Total revenue. (4)See “Note 10, Earnings (Loss) Per Share” of the unaudited quarterly consolidated financial statements. 3 First Quarter 2026 Review* Total revenue for the first quarter of 2026 was $795.2 million, an increase of 15.2% compared to $690.2 million in the prior-year period. This increase was primarily due to continued organic revenue growth of 11.8%, driven by new client wins and expanded relationships with existing clients, coupled with continued expansion of the specialty and E&S markets, revenue from acquisitions completed within the trailing twelve months ended March 31, 2026, and growth in contingent commissions. We experienced growth across the majority of our casualty lines, offset by a moderate decline in our property portfolio. Total operating expenses for the first quarter of 2026 were $700.6 million, an 18.8% increase compared to $589.9 million in the prior-year period. This increase was primarily due to higher Compensation and benefits expenses resulting from growth in headcount and revenue and an increase in Restructuring and related expense due to the Empower Program initiated in the first quarter of 2026. General and administrative expense also increased compared to the prior-year period due to an increase in professional services and IT charges, as well as costs directly linked to revenue growth, recruiter fees, higher expenses to accommodate both organic and inorganic revenue growth, and an increase in Restructuring and related expense due to the Empower Program, partially offset by lower Acquisition-related expenses. Net income for the first quarter of 2026 increased to $40.6 million, compared to a loss of $(4.4) million in the prior- year period. The increase was due to strong revenue growth and lower Income tax expense, partially offset by higher Total operating expenses compared to the prior-year period. Adjusted EBITDAC grew 15.7% to $232.0 million from $200.5 million in the prior-year period. Adjusted EBITDAC margin for the quarter was 29.2%, compared to 29.1% in the prior-year period. The increase in Adjusted EBITDAC was driven primarily by strong revenue growth, partially offset by higher Adjusted compensation and benefits expense, as well as higher Adjusted general and administrative expense. Adjusted net income for the first quarter of 2026 increased 21.2% to $130.7 million, compared to $107.8 million in the prior-year period. Adjusted net income margin was 16.4%, compared to 15.6% in the prior-year period. Adjusted diluted earnings per share for the first quarter of 2026 increased 20.5% to $0.47, compared to $0.39 in the prior- year period. *For the definition of each of the non-GAAP measures referred to above, as well as a reconciliation of such non-GAAP measures to their most directly comparable GAAP measures, see “Non-GAAP Financial Measures and Key Performance Indicators” below. 4 First Quarter 2026 Net Commissions and Fees by Specialty and Revenue by Type Growth in Net commissions and fees in all specialties was primarily driven by strong organic growth. Three Months Ended March 31, (in thousands, except percentages) 2026 % of total 2025 % of total Change Wholesale Brokerage $377,796 48.3% $360,788 53.4% $17,008 4.7% Binding Authority 110,000 14.0 101,950 15.1 8,050 7.9 Underwriting Management 295,107 37.7 213,390 31.5 81,717 38.3 Total Net commissions and fees $782,903 $676,128 $106,775 15.8% The following tables sets forth our revenue by type of commission and fees: Three Months Ended March 31, (in thousands, except percentages) 2026 % of total 2025 % of total Change Net commissions and policy fees $717,553 91.7% $623,966 92.3% $93,587 15.0% Supplemental and contingent commissions 49,117 6.3 37,773 5.6 11,344 30.0 Loss mitigation and other fees 16,233 2.0 14,389 2.1 1,844 12.8 Total Net commissions and fees $782,903 $676,128 $106,775 15.8% Liquidity and Financial Condition As of March 31, 2026, the Company had Cash and cash equivalents of $154.7 million and outstanding debt principal of $3.6 billion. Capital Return In the first quarter, the Company returned approximately $64.8 million to shareholders through $40.0 million of Class A common stock repurchases, representing 1.0 million shares, and $24.8 million of dividends and distributions. As of March 31, 2026, the Company had $260.0 million of remaining authorization under its share repurchase program. Additionally, on April 30, 2026, the Company’s board of directors declared a quarterly dividend of $0.13 per share on the outstanding Class A common stock. The quarterly dividend will be payable on May 26, 2026, to stockholders of record as of the close of business on May 12, 2026. A portion of the dividend, $0.06 per share, will be funded by free cash flow from Ryan Specialty, LLC and will be paid to all holders of the Company’s Class A common stock and the holders of the LLC Common Units (as defined below). Full Year 2026 Guidance* The Company is updating its full year 2026 guidance for Organic Revenue Growth Rate and Adjusted EBITDAC Margin as follows: •We are guiding to an Organic Revenue Growth Rate in the mid-single digits for 2026 •We are guiding to an Adjusted EBITDAC Margin that is down 100 - 150 basis points for 2026, as compared to the prior year 5 *For a definition of Organic revenue growth rate and Adjusted EBITDAC margin, see “Non-GAAP Financial Measures and Key Performance Indicators” below. Executive Chairman Stock Option Program On April 30, 2026, the Company announced a special, one-time stock option grant program, funded entirely by Executive Chairman, Patrick G. Ryan, through the Ryan Stock Option Trust. The program is designed to be net neutral to the Company's outstanding share count and is intended to support employee alignment. Please refer to the Company's 8-K filed with the SEC for more information. Conference Call Information Ryan Specialty will hold a conference call to discuss the financial results at 4:45pm Eastern Time on April 30, 2026. Interested parties may access the conference call through the live webcast, which can be accessed at https://ryan- specialty-q1-2026-earnings-call.open-exchange.net/registration or by visiting the Company’s Investor Relations website. Please join the live webcast at least 10 minutes prior to the scheduled start time. A webcast replay of the call will be available on the Company’s website at ryanspecialty.com in its Investors section for one year following the call. About Ryan Specialty Founded in 2010, Ryan Specialty (NYSE: RYAN) is a service provider of specialty products and solutions for insurance brokers, agents, and carriers. Ryan Specialty provides distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter with delegated authority from insurance carriers. Our mission is to provide industry-leading innovative specialty insurance solutions for insurance brokers, agents, and carriers. Learn more at ryanspecialty.com. Forward-Looking Statements All statements in this release and in the corresponding earnings call that are not historical are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and involve substantial risks and uncertainties. For example, all statements the Company makes relating to its estimated and projected costs, expenditures, cash flows, growth rates and financial results, its plans, anticipated amount and timing of cost savings relating to the restructuring plan, or its plans and objectives for future operations, growth initiatives, or strategies and the statements under the caption “Full Year 2026 Outlook” are forward-looking statements. Words such as “anticipate,” “estimate,” “expect,” “project,” “plan,” “intend,” “believe,” “may,” “will,” “should,” “can have,” “likely” and variations of such words and similar expressions are intended to identify such forward-looking statements. All forward-looking statements are subject to risks and uncertainties, known and unknown, that may cause actual results to differ materially from those that the Company expected. Specific factors that could cause such a difference include, but are not limited to, those disclosed previously in the Company’s filings with the Securities and Exchange Commission (“SEC”). For more detail on the risk factors that may affect the Company’s results, see the section entitled “Risk Factors” in our most recent annual report on Form 10-K filed with the SEC, and in other documents filed with, or furnished to, the SEC. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. Given these factors, as well as other variables that may affect the Company’s operating results, you are cautioned not to place undue reliance on these forward-looking statements, not to assume that past financial performance will be a reliable indicator of future performance, and not to use historical trends to anticipate results or trends in future periods. The forward-looking statements included in this press release and on the related earnings call relate only to events as of the date hereof. The Company does not undertake, and expressly disclaims, any duty or obligation to update publicly any forward-looking statement after the date of this release, whether as a result of new information, future events, changes in assumptions, or otherwise. 6 Non-GAAP Financial Measures and Key Performance Indicators In assessing the performance of the Company’s business, non-GAAP financial measures are used that are derived from the Company’s consolidated financial information, but which are not presented in the Company’s consolidated financial statements prepared in accordance with GAAP. The Company considers these non-GAAP financial measures to be useful metrics for management and investors to facilitate operating performance comparisons from period to period by excluding potential differences caused by variations in capital structures, tax positions, depreciation, amortization, and certain other items that the Company believes are not representative of its core business. The Company uses the following non-GAAP measures for business planning purposes, in measuring performance relative to that of its competitors, to help investors to understand the nature of the Company’s growth, and to enable investors to evaluate the run-rate performance of the Company. Non-GAAP financial measures should be viewed as supplementing, and not as an alternative or substitute for, the consolidated financial statements prepared and presented in accordance with GAAP. The footnotes to the reconciliation tables below should be read in conjunction with the unaudited consolidated quarterly financial statements in the Company’s Quarterly Report on form 10-Q filed with the SEC. Industry peers may provide similar supplemental information but may not define similarly-named metrics in the same way and may not make identical adjustments. Organic revenue growth rate: Organic revenue growth rate represents the percentage change in Net commissions and fees, as compared to the same period for the prior year, adjusted to eliminate revenue attributable to acquisitions for the first twelve months of ownership, revenue attributable to sold businesses for the subsequent twelve months after the sale, and other items such as contingent commissions and the impact of changes in foreign exchange rates. Adjusted compensation and benefits expense: Adjusted compensation and benefits expense is defined as Compensation and benefits expense adjusted to reflect items such as (i) equity-based compensation, (ii) acquisition and restructuring related compensation expenses, and (iii) other exceptional or non-recurring compensation expenses, as applicable. The most directly comparable GAAP financial metric is Compensation and benefits expense. Adjusted general and administrative expense: Adjusted general and administrative expense is defined as General and administrative expense adjusted to reflect items such as (i) acquisition and restructuring related general and administrative expenses, and (ii) other exceptional or non-recurring general and administrative expenses, as applicable. The most directly comparable GAAP financial metric is General and administrative expense. Adjusted compensation and benefits expense ratio: Adjusted compensation and benefits expense ratio is defined as the Adjusted compensation and benefits expense as a percentage of Total revenue. The most directly comparable GAAP financial metric is Compensation and benefits expense ratio. Adjusted general and administrative expense ratio: Adjusted general and administrative expense ratio is defined as the Adjusted general and administrative expense as a percentage of Total revenue. The most directly comparable GAAP financial metric is General and administrative expense ratio. Adjusted EBITDAC: Adjusted EBITDAC is defined as Net income before Interest expense, net, Income tax expense, Depreciation, Amortization, and Change in contingent consideration, adjusted to reflect items such as (i) equity- based compensation, (ii) acquisition-related expenses, and (iii) other exceptional or non-recurring items, as applicable. Acquisition-related expense includes one-time diligence, transaction-related, and integration costs. Acquisition-related long-term incentive compensation arises from long-term incentive plans associated with acquisitions. These plans require service requirements, and in some cases performance targets, to be met in order to be earned. Restructuring and related expense consists of compensation and benefits, contractors, professional services, and license fees related to the Empower Program, which was initiated at the beginning of 2026. The compensation and benefits expense includes severance as well as employment costs related to services rendered between the notification and termination dates and other termination payments. Amortization and expense is composed of charges related to discontinued prepaid incentive programs. For the three months ended March 31, 2026, Other non-operating income consisted of $0.5 million of forfeitures of vested equity awards, $0.1 million of 7 seller reimbursement of acquisition-related retention incentives, and $0.1 million of sublease income. For the three months ended March 31, 2025, Other non-operating income consisted of $0.3 million of seller reimbursement of acquisition-related retention incentives and $0.1 million of sublease income. Equity-based compensation reflects non-cash equity-based expense. IPO related expenses consist of compensation-related expense primarily related to the expense for new awards issued at IPO, as well as expense related to the revaluation of existing equity awards at IPO. Adjusted EBITDAC margin: Adjusted EBITDAC margin is defined as Adjusted EBITDAC as a percentage of Total revenue. The most directly comparable GAAP financial metric is Net income margin. Adjusted net income: Adjusted net income is defined as tax-effected earnings before amortization and certain items of income and expense, gains and losses, equity-based compensation, acquisition related long-term incentive compensation, acquisition-related expenses, costs associated with our IPO, and certain exceptional or non-recurring items. The Company will be subject to United States federal income taxes, in addition to state, local, and foreign taxes, with respect to its allocable share of any net taxable income of Ryan Specialty, LLC (together with its parent New Ryan Specialty, LLC and their subsidiaries, the “LLC”). For comparability purposes, this calculation incorporates the impact of federal and state statutory tax rates on 100% of the Company’s adjusted pre-tax income as if the Company owned 100% of Ryan Specialty, LLC. The most directly comparable GAAP financial metric is Net income. Adjusted net income margin: Adjusted net income margin is defined as Adjusted net income as a percentage of Total revenue. The most directly comparable GAAP financial metric is Net income margin. Adjusted diluted earnings per share: Adjusted diluted earnings per share is defined as Adjusted net income divided by diluted shares outstanding after adjusting for the effect if 100% of the outstanding LLC Common Units (“LLC Common Units”), together with the shares of Class B common stock, vested Class C Incentive Units, vested but unexercised Options, and unvested equity awards were exchanged into shares of Class A common stock as if 100% of unvested equity awards were vested. The most directly comparable GAAP financial metric is Diluted earnings per share. Credit Adjusted EBITDAC: Credit Adjusted EBITDAC is defined as Adjusted EBITDAC as further adjusted without duplication for: acquired EBITDAC from the beginning of the applicable twelve month reference period through the acquisition close date, certain annualized run rate expected cost savings and initiatives, and certain other adjustments as permitted in calculating leverage ratios under our debt agreements. The Company presents Credit Adjusted EBITDAC as an additional measure of liquidity and leverage. The calculation of Credit Adjusted EBITDAC pursuant to our debt agreements permits certain estimates and assumptions that may differ from actual results. The summary unaudited consolidated financial data presented for the twelve months ended March 31, 2026, was derived by adding the consolidated financial data of the Company for the twelve months ended December 31, 2025, to the consolidated financial data of the Company for the three months ended March 31, 2026, and subtracting the consolidated financial data of the Company for the three months ended March 31, 2025. The summary unaudited consolidated financial data for the twelve months ended March 31, 2026, has been prepared for illustrative purposes only and is not necessarily representative of our results of operations for any future period or our financial condition at any future date. The reconciliation of the above non-GAAP measures to each of their most directly comparable GAAP financial measure is set forth in the reconciliation table accompanying this release. With respect to the Organic revenue growth rate and Adjusted EBITDAC margin outlook presented in the “Full Year 2026 Outlook” section of this press release, the Company is unable to provide a comparable outlook for, or a reconciliation to, Total revenue growth rate or Net income margin because it cannot provide a meaningful or accurate calculation or estimation of certain reconciling items without unreasonable effort. Its inability to do so is due to the inherent difficulty in forecasting the timing of items that have not yet occurred and quantifying certain amounts that are necessary for such reconciliation, including variations in effective tax rate, expenses to be incurred for acquisition activities, and other one-time or exceptional items. 8 Contacts: Investor Relations Nicholas Mezick VP, Investor Relations Ryan Specialty IR@ryanspecialty.com Phone: (312) 784-6152 Media Relations Alice Phillips Topping SVP, Chief Marketing & Communications Officer Ryan Specialty Alice.Topping@ryanspecialty.com Phone: (312) 635-5976 9 Consolidated Statements of Income (Unaudited) Three Months Ended March 31, (in thousands, except percentages and per share data) 2026 2025 Revenue Net commissions and fees $782,903 $676,128 Fiduciary investment income 12,326 14,038 Total revenue $795,229 $690,166 Expenses Compensation and benefits 495,176 430,289 General and administrative 108,761 106,060 Amortization 65,340 64,985 Depreciation 4,062 2,639 Change in contingent consideration 27,294 (14,042) Total operating expenses $700,633 $589,931 Operating income $94,596 $100,235 Interest expense, net 53,733 54,508 Income from equity method investments (5,531) (4,937) Other non-operating income (711) (377) Income before income taxes $47,105 $51,041 Income tax expense 6,508 55,430 Net income (loss) $40,597 $(4,389) GAAP financial measures Total revenue $795,229 $690,166 Net commissions and fees 782,903 676,128 Compensation and benefits 495,176 430,289 General and administrative 108,761 106,060 Net income (loss) 40,597 (4,389) Compensation and benefits expense ratio (1) 62.3 % 62.3 % General and administrative expense ratio (2) 13.7 % 15.4 % Net income (loss) margin (3) 5.1 % (0.6 %) Earnings (loss) per share (4) $0.14 $(0.22) Diluted earnings (loss) per share (4) $0.13 $(0.22) Non-GAAP Financial Measures (Unaudited) Three Months Ended March 31, (in thousands, except percentages and per share data) 2026 2025 Non-GAAP financial measures* Organic revenue growth rate 11.8 % 12.9 % Adjusted compensation and benefits expense $461,832 $397,428 Adjusted compensation and benefits expense ratio 58.1 % 57.6 % Adjusted general and administrative expense $101,365 $92,237 Adjusted general and administrative expense ratio 12.7 % 13.4 % Adjusted EBITDAC $232,033 $200,501 Adjusted EBITDAC margin 29.2 % 29.1 % Adjusted net income $130,728 $107,839 Adjusted net income margin 16.4 % 15.6 % Adjusted diluted earnings per share $0.47 $0.39 10 Consolidated Balance Sheets (Unaudited) (in thousands, except share and per share data) March 31, 2026 December 31, 2025 ASSETS CURRENT ASSETS Cash and cash equivalents $154,650 $158,322 Commissions and fees receivable – net 565,259 488,951 Fiduciary cash and receivables 4,764,338 4,298,920 Prepaid incentives – net 15,326 13,550 Other current assets 79,255 100,437 Total current assets $5,578,828 $5,060,180 NON-CURRENT ASSETS Goodwill 3,217,450 3,225,021 Customer relationships 1,433,397 1,496,885 Other intangible assets 127,052 119,621 Prepaid incentives – net 29,718 27,849 Equity method investments 116,431 109,982 Property and equipment – net 66,138 69,461 Lease right-of-use assets 125,802 130,480 Deferred tax assets 305,565 310,138 Other non-current assets 11,257 14,554 Total non-current assets $5,432,810 $5,503,991 TOTAL ASSETS $11,011,638 $10,564,171 LIABILITIES AND STOCKHOLDERS’ EQUITY CURRENT LIABILITIES Accounts payable and accrued liabilities $341,742 $284,403 Accrued compensation 257,275 519,251 Operating lease liabilities 27,189 25,987 Tax Receivable Agreement liabilities 30,047 — Short-term debt and current portion of long-term debt 35,364 60,187 Fiduciary liabilities 4,764,338 4,298,920 Total current liabilities $5,455,955 $5,188,748 NON-CURRENT LIABILITIES Accrued compensation 81,362 70,096 Operating lease liabilities 146,200 153,089 Long-term debt 3,533,913 3,291,462 Tax Receivable Agreement liabilities 430,797 458,997 Deferred tax liabilities 47,354 49,834 Other non-current liabilities 97,003 97,894 Total non-current liabilities $4,336,629 $4,121,372 TOTAL LIABILITIES $9,792,584 $9,310,120 STOCKHOLDERS’ EQUITY Class A common stock ($0.001 par value; 1,000,000,000 shares authorized, 128,867,457 and 129,603,426 shares issued and outstanding at March 31, 2026, and December 31, 2025, respectively) 129 130 Class B common stock ($0.001 par value; 984,748,069 shares authorized and 134,351,649 shares issued and outstanding at March 31, 2026; 1,000,000,000 shares authorized and 134,508,885 shares issued and outstanding at December 31, 2025) 134 135 Preferred stock ($0.001 par value; 500,000,000 shares authorized, 0 shares issued and outstanding at March 31, 2026, and December 31, 2025) — — Additional paid-in capital 506,021 513,610 Retained earnings 120,528 120,353 Accumulated other comprehensive income 9,390 13,845 Total stockholders’ equity attributable to Ryan Specialty Holdings, Inc. $636,202 $648,073 Non-controlling interests 582,852 605,978 Total stockholders’ equity $1,219,054 $1,254,051 TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $11,011,638 $10,564,171 11 Consolidated Statements of Cash Flows (Unaudited) Three Months Ended March 31, (in thousands) 2026 2025 CASH FLOWS FROM OPERATING ACTIVITIES Net income (loss) $40,597 $(4,389) Adjustments to reconcile net income (loss) to cash flows provided by operating activities: Income from equity method investments (5,531) (4,937) Amortization 65,340 64,985 Depreciation 4,062 2,639 Prepaid and deferred compensation expense 13,700 10,799 Non-cash equity-based compensation 17,351 19,873 Amortization of deferred debt issuance costs 2,422 2,374 Amortization of interest rate cap premium — 1,739 Deferred income tax expense 3,142 2,720 Deferred income tax expense from common control reorganization — 48,115 Changes in operating assets and liabilities, net of acquisitions: Commissions and fees receivable – net (77,800) (17,088) Accrued interest liability (21,470) (11,801) Other current and non-current assets 18,524 41,130 Other current and non-current liabilities (227,748) (298,984) Total cash flows used in operating activities $(167,411) $(142,825) CASH FLOWS FROM INVESTING ACTIVITIES Business combinations – net of cash acquired and cash held in a fiduciary capacity — (555,641) Capital expenditures (13,265) (16,730) Asset acquisitions — (664) Total cash flows used in investing activities $(13,265) $(573,035) CASH FLOWS FROM FINANCING ACTIVITIES Borrowings on Revolving Credit Facility 524,942 574,056 Repayments on Revolving Credit Facility (279,375) (150,000) Debt issuance costs paid — (1,548) Repayment of term debt (4,250) (4,250) Receipt of contingently returnable consideration 3,140 1,927 Payment of contingent consideration (17) (25,150) Tax distributions to non-controlling LLC Unitholders (1,294) — Receipt of taxes related to net share settlement of equity awards 1,714 1,569 Taxes paid related to net share settlement of equity awards (1,496) (1,700) Class A common stock dividends and Dividend Equivalents paid (16,795) (15,074) Distributions and Declared Distributions paid to non-controlling LLC Unitholders (8,071) (6,796) Repurchases of Class A common stock (40,019) — Payments related to Ryan Re preferred units — (85) Net change in fiduciary liabilities (92,194) (36,109) Total cash flows provided by financing activities $86,285 $336,840 Effect of changes in foreign exchange rates on cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity (5,191) 10,081 NET CHANGE IN CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD IN A FIDUCIARY CAPACITY $(99,582) $(368,939) CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD IN A FIDUCIARY CAPACITY —Beginning balance 1,584,470 1,680,805 CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD IN A FIDUCIARY CAPACITY —Ending balance $1,484,888 $1,311,866 Reconciliation of cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity Cash and cash equivalents $154,650 $203,549 Cash and cash equivalents held in a fiduciary capacity 1,330,238 1,108,317 Total cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity $1,484,888 $1,311,866 12 Reconciliation of Organic Revenue Growth Rate Three Months Ended March 31, (in thousands, except percentages) 2026 2025 Current period Net commissions and fees revenue $782,903 $676,128 Less: Current period contingent commissions (42,373) (30,463) Less: Revenue attributable to sold businesses (13) (146) Net commissions and fees revenue excluding contingent commissions $740,517 $645,519 Prior period Net commissions and fees revenue $676,128 $537,887 Less: Prior year contingent commissions (30,463) (24,503) Less: Revenue attributable to sold businesses (657) (539) Prior period Net commissions and fees revenue excluding contingent commissions $645,008 $512,845 Change in Net commissions and fees revenue excluding contingent commissions $95,509 $132,674 Less: Mergers and acquisitions Net commissions and fees revenue excluding contingent commissions (15,246) (67,155) Impact of change in foreign exchange rates (3,863) 430 Organic revenue growth (Non-GAAP) $76,400 $65,949 Net commissions and fees revenue growth rate (GAAP) 15.8 % 25.7 % Less: Impact of contingent commissions (1) (1.0) 0.2 Net commissions and fees revenue excluding contingent commissions growth rate (2) 14.8 % 25.9 % Less: Mergers and acquisitions Net commissions and fees revenue excluding contingent commissions (3) (2.4) (13.1) Impact of change in foreign exchange rates (4) (0.6) 0.1 Organic Revenue Growth Rate (Non-GAAP) 11.8 % 12.9 % (1)Calculated by subtracting Net commissions and fees revenue growth rate from net commissions and fees revenue excluding contingent commissions growth rate and revenue from sold businesses. (2)Calculated by dividing the change in Total net commissions & fees revenue excluding contingent commissions by prior year net commissions and fees excluding contingent commissions and revenue from sold businesses. (3)Calculated by taking the mergers and acquisitions net commissions and fees revenue excluding contingent commissions, representing the first 12 months of net commissions and fees revenue generated from acquisitions, divided by prior period net commissions and fees revenue excluding contingent commissions and revenue from sold businesses. (4)Calculated by taking the change in foreign exchange rates divided by prior period net commissions and fees revenue excluding contingent commissions and revenue from sold businesses. 13 Reconciliation of Adjusted Compensation and Benefits Expense to Compensation and Benefits Expense Three Months Ended March 31, (in thousands, except percentages) 2026 2025 Total revenue $795,229 $690,166 Compensation and benefits expense $495,176 $430,289 Acquisition-related expense (3,411) (3,479) Acquisition related long-term incentive compensation (9,287) (8,331) Restructuring and related expense (2,465) — Amortization and expense related to discontinued prepaid incentives (830) (1,178) Equity-based compensation (14,309) (14,569) Initial public offering related expense (3,042) (5,304) Adjusted compensation and benefits expense (1) $461,832 $397,428 Compensation and benefits expense ratio 62.3% 62.3% Adjusted compensation and benefits expense ratio 58.1% 57.6% (1)Adjustments made to Compensation and benefits expense are described in the definition of Adjusted EBITDAC in “Non-GAAP Financial Measures and Key Performance Indicators.” Reconciliation of Adjusted General and Administrative Expense to General and Administrative Expense Three Months Ended March 31, (in thousands, except percentages) 2026 2025 Total revenue $795,229 $690,166 General and administrative expense $108,761 $106,060 Acquisition-related expense (3,990) (13,823) Restructuring and related expense (3,406) — Adjusted general and administrative expense (1) $101,365 $92,237 General and administrative expense ratio 13.7% 15.4% Adjusted general and administrative expense ratio 12.7% 13.4% (1)Adjustments made to General and administrative expense are described in the definition of Adjusted EBITDAC in “Non-GAAP Financial Measures and Key Performance Indicators.” 14 Reconciliation of Adjusted EBITDAC to Net Income Three Months Ended March 31, (in thousands, except percentages) 2026 2025 Total revenue $795,229 $690,166 Net income (loss) $40,597 $(4,389) Interest expense, net 53,733 54,508 Income tax expense 6,508 55,430 Depreciation 4,062 2,639 Amortization 65,340 64,985 Change in contingent consideration (1) 27,294 (14,042) EBITDAC $197,534 $159,131 Acquisition-related expense 7,402 17,302 Acquisition related long-term incentive compensation 9,287 8,331 Restructuring and related expense 5,871 — Amortization and expense related to discontinued prepaid incentives 830 1,178 Other non-operating income (711) (377) Equity-based compensation 14,309 14,569 IPO related expenses 3,042 5,304 Income from equity method investments (5,531) (4,937) Adjusted EBITDAC $232,033 $200,501 Net income (loss) margin 5.1% (0.6)% Adjusted EBITDAC margin 29.2% 29.1% (1)For the three months ended March 31, 2025, Change in contingent consideration included a $12.4 million decrease in valuation of the US Assure contingent consideration as a result of increased loss ratios impacting projected profit commissions. 15 Reconciliation of Adjusted Net Income to Net Income Three Months Ended March 31, (in thousands, except percentages) 2026 2025 Total revenue $795,229 $690,166 Net income (loss) $40,597 $(4,389) Income tax expense 6,508 55,430 Amortization 65,340 64,985 Amortization of deferred debt issuance costs (1) 2,422 2,374 Change in contingent consideration 27,294 (14,042) Acquisition-related expense 7,402 17,302 Acquisition related long-term incentive compensation 9,287 8,331 Restructuring and related expense 5,871 — Amortization and expense related to discontinued prepaid incentives 830 1,178 Other non-operating income (711) (377) Equity-based compensation 14,309 14,569 IPO related expenses 3,042 5,304 Income from equity method investments (5,531) (4,937) Adjusted income before income taxes (2) $176,660 $145,728 Adjusted income tax expense (3) (45,932) (37,889) Adjusted net income $130,728 $107,839 Net income (loss) margin 5.1% (0.6)% Adjusted net income margin 16.4% 15.6% (1)Interest expense, net includes amortization of deferred debt issuance costs. (2)Adjustments made to Net income are described in the definition of Adjusted EBITDAC in “Non-GAAP Financial Measures and Key Performance Indicators.” (3)The Company is subject to United States federal income taxes, in addition to state, local, and foreign taxes, with respect to our allocable share of any net taxable income of the LLC. For the three months ended March 31, 2026 and 2025, this calculation of adjusted income tax expense is based on a federal statutory rate of 21% and a combined state income tax rate net of federal benefits of 5.00% on 100% of our adjusted income before income taxes as if the Company owned 100% of the LLC. 16 Reconciliation of Adjusted Diluted Earnings per Share to Diluted Earnings per Share Three Months Ended March 31, 2026 2025 Earnings (loss) per share of Class A common stock – diluted $0.13 $(0.22) Less: Net income attributed to dilutive shares (1) — — Plus: Impact of all LLC Common Units exchanged for Class A shares (2) 0.02 0.20 Plus: Adjustments to Adjusted net income (3) 0.33 0.43 Plus: Dilutive impact of unvested equity awards (4) (0.01) (0.02) Adjusted diluted earnings per share $0.47 $0.39 (Share count in ’000) Weighted-average shares of Class A common stock outstanding – diluted 137,341 125,420 Plus: Impact of all LLC Common Units exchanged for Class A shares (2) 134,476 136,064 Plus: Dilutive impact of unvested equity awards (4) 6,824 17,783 Adjusted diluted earnings per share diluted share count 278,641 279,267 (1)Adjustment removes the impact of Net income attributed to dilutive awards to arrive at Net income (loss) attributable to Ryan Specialty Holdings, Inc. For the three months ended March 31, 2026, this removes $0.2 million of Net income on 137.3 million Weighted-average shares of Class A common stock outstanding - diluted, respectively. See “Note 10, Earnings (Loss) Per Share” of the unaudited quarterly consolidated financial statements. (2)For comparability purposes, this calculation incorporates the Net income that would be distributable if all LLC Common Units (together with shares of Class B common stock) were exchanged for shares of Class A common stock. For the three months ended March 31, 2026 and 2025, this includes $23.0 million and $23.3 million of Net income, respectively, on 271.8 million and 261.5 million Weighted-average shares of Class A common stock outstanding - diluted, respectively. See “Note 10, Earnings (Loss) Per Share” of the unaudited quarterly consolidated financial statements. (3)Adjustments to Adjusted net income are described in the footnotes of the reconciliation of Adjusted net income to Net income (loss) in “Adjusted Net Income and Adjusted Net Income Margin” on 271.8 million and 261.5 million Weighted-average shares of Class A common stock outstanding - diluted for the three months ended March 31, 2026 and 2025, respectively. (4)For comparability purposes and to be consistent with the treatment of the adjustments to arrive at Adjusted net income, the dilutive effect of unvested equity awards as well as outstanding vested options and vested Class C Incentive Units is calculated using the treasury stock method as if the weighted-average unrecognized cost associated with the awards was $0 over the period, less any unvested equity awards determined to be dilutive within the Diluted EPS calculation disclosed in “Note 10, Earnings (Loss) Per Share” of the unaudited quarterly consolidated financial statements. For the three months ended March 31, 2026 and 2025, 6.8 million and 17.8 million shares were added to the calculation, respectively. 17 Reconciliation of Credit Adjusted EBITDAC to Net Income (in thousands) Twelve Months Ended March 31, 2026 Total Revenue $3,156,189 Net Income $259,143 Interest expense, net 221,609 Income tax expense 30,105 Depreciation 14,512 Amortization 274,781 Change in contingent consideration 54,458 EBITDAC $854,608 Acquisition-related expense 62,201 Acquisition related long-term incentive compensation 27,537 Restructuring and related expense 5,871 Amortization and expense related to discontinued prepaid incentives 3,984 Other non-operating income (1,026) Equity-based compensation 49,404 IPO related expenses 17,525 Income from equity method investments (21,830) Adjusted EBITDAC (1) $998,274 Credit adjustments (2) 48,387 Credit Adjusted EBITDAC $1,046,661 (1)Adjustments made to Net income are described in the definition of Adjusted EBITDAC in “Non-GAAP Financial Measures and Key Performance Indicators”. (2)Adjustments made to Adjusted EBITDAC represent (without duplication) additional adjustments permitted under our debt agreements.